Stock 1228 CANBRIDGE PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. CANbridge Pharmaceuticals Inc.

Equities

1228

KYG1821D1097

Delayed Hong Kong S.E.
Other stock markets
 04:48:16 10/05/2024 BST 		5-day change 1st Jan Change
0.305 HKD -14.08% Intraday chart for CANbridge Pharmaceuticals Inc. -32.22% -69.19%
04-23 Canbridge Pharmaceuticals Shelves Glioblastoma Drug After Phase II Clinical Trials MT
04-22 CANbridge Pharmaceuticals Inc. Announces Results of CAN008 Phase II Clinical Trial for the Treatment of Glioblastoma Multiforme CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1228 Stock
  4. News CANbridge Pharmaceuticals Inc.
  5. Analyst Reco.